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SECTION - I 
EALES DISEASE 
INTRODUCTION 
 Eales Disease can be defined as primary idiopathic perivasculitis 
unaccompanied by other ocular inflammatory disorders or obvious systemic 
disease.  The most striking feature of the inflammatory disease is the occurrence 
of hemorrhage in the retina or in the vitreous or the recurrence of hemorrhage in 
the later and arising there from, the complications. The most feared are retinitis  
proliferance detachment of retina, complicated cataract and secondary glaucoma 
in the order of frequency. 
 
HISTORICAL ASPECTS  
Eales disease was first described by Henry Eales a British 
ophthalmologist in 1880 and 1882. He found it in seven young, male patients 
ranging in age from 14 - 29 yrs. with recurrent retinal hemorrhages. 
In addition these patients had histories of headache, variation in 
peripheral circulation, chronic constipation and epistaxis. 
He concluded that the repeated hemorrhages occurred as a “neurosis” in 
the absence of obvious constitutional disease and retinal inflammation but, were 
associated with constipation and epistaxis the former being due to vasomotor 
contraction and subsequent muscular inhibition and the latter to a compensatory 
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capillary dilatation. In the century that has followed he has been honoured with 
the eponym for the disease (Eales disease) 
 
Duke - elder felt that Eales disease was not a distinct clinical entity but 
instead represented the clinical manifestation of many diseases. 
Elliot first recognized the inflammation of retinal vein and described it as 
periphlebitis retinae. Subsequently several investigators documented both 
venular and arteriolar inflammation.  
 
The researches of Axenfeld and Stock (1909 -11) drew attention to the 
aetiological significants of tuberculosis a relation histologically proved by 
Fleisher (1913-14) Cords suggested the grouping together of recurrent vitreous 
hemorrhage, perivasculitis, retinitis proliferans and the exudative retinitis of 
coats into one group.   
 
After the observation there was a tendency especially among German 
writers to ascribe all cases of recurrent hemorrhages to tuberculous retinal 
periphlebitis. On the other hand, many other causes were suggested particularly 
endocrine disturbances by French and focal infection by British and American 
writers, and blood dyscrasias were implicated by various authors. Even today 
the aetilogy still remains idiopathic. 
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RETINAL ANGIOGENESIS 
 The terminal portion of the primitive ophthalmic artery invade the 
embryonic fissure of the human eye at about 5 mm stage. The fissure close 
between the fifth and seventh week. The vessel remain in the optic cup and 
becomes the hyaloid artery. It probably functions, at least initially to supply the 
lens and retina. At the fourth month of gestation, spindle shaped mesenchymal 
cells arise from the hyaloid artery where it enter the optic disc. The formation of 
the primitive vessels occur, behind the advancing edge of the invading 
mesenchymal cells. Endothelial cells differentiate first and adjacent cells form 
junctional complexes, which invade both zonulae occludentes and gap 
junctions. 
 
 As the vessel matures, the lumina enlarge and become patent.   Pericytes 
are present from an early stage. A prominent feature of the developing 
vasculature is the association of mononuclear phagocytic cells which are 
thought to have a role in angiogenesis. Retinal Vascularisation proceeds from 
the centre to the periphery. Between 24-26 weeks of gestation, small blood 
vessels develop in the ganglion cell layer at the foveal slope. By a process of 
remodeling and retraction of the primitive capillary network, the adult pattern of 
arterioles, veins and capillaries is established.     
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DUKE ELDER’S CLASSIFICATION 
 
1. Vasuculitis secondary to uveitis. 
2. Vasculitis secondary to systemic diseases. 
3. Apparently primary vasculitis. 
COGAN DIVIDED VASUCULITIS INTO THREE GROUPS 
 (1969, William Mckenzie centerary symposium on the circulation in 
health and diseases, kimpton London) 
 
1. Mild papillophlebitis 
2. Moderate vasculitis - Bilateral - Arteriole/veins affected 
3. Severe vasculitis - Arterioles involved more than veins. 
 
RECENT CLASSIFICATION 
1. Primary vasculitis 
2. Vasculitis secondary to ocular disease 
3. Vasculitis secondary to systemic disease 
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FEATURES OF VASCULITIS 
SIGNS OF VASCULITIS 
 
 Sheathing of vessels 
 Narrowing of vessles 
 Obliteration 
 Peri-vascular oedema 
 
EFFECTS OF VASCULITIS 
 
- Oedema 
- Haemorrhage 
- Vitreous haze 
- Anterior uveitis 
- Complicated cataract 
- Hypoxia 
- Neo-vascularization 
- Retinitis proliferans 
- Retinal detachment 
- Secondary glaucoma 
 
As a result 
Of 
inflammation 
As a result of  
Occlusion 
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EPIDEMIOLOGY 
 
 Eales disease was initially reported in the United Kingdom but 
subsequently several series have been reported from USA, Canada, Germany, 
Greece, Korea and Turkey. In addition several isolated case reports from other 
countries are available. The disease is now seen more commonly in the Indian 
subcontinent. At a tertiary referal eye institute in India, the disease was seen in 1 
in 150-200 ochthalmic patients.  
 Eales disease usually affects healthy young adult. Male predominance has 
been reported in a majority of the series. The predominant age of onset of 
symptom is between 20 and 30 years.      
 
AETIOLOGY   
 Till date Eale’s disease remains an “Idiopathic Disease” however a 
number of aetiologies have been suggested.  
1. Retinal circulation bears an analogy to the cerebral in which a similar 
perivasculitis may occur, the origin of which remains an enigma.  
2. Most authors agree that tuberculosis figures predominantly. The freedom 
of the anterior uvea from inflammation in the majority of cases, the 
widespread peripheral distribution of the lesions in the terminal 
circulation of the retina in many of them, as well as the demonstration of 
active tuberculosis else where in the body, provide some evidence of its 
 7
haematogenous origin. The fact however that most cases show no sign of 
active infection but evidence of old lesion has inclined most author to 
consider that it is usually a tuberculo allergic process certainly the 
number of patients who have positive dermal test to tuberculoses lend 
support to the view. Tuberculin has been noted to cause a perivasculitis in 
the eye after Therapeutic injections or even dermal diagnostic test. 
Periphlebitis was first reported following B.C.G. vaccination by Franke / 
1944 and further cases were recorded by Haar (1951) Miettinin (1958) 
and Frandsen (1959) 
3. Focal infection and dental infection particularly used to be frequently 
quoted in the literature. A typical case, claimed to be due to metastasis 
from an abscess in the skin was reported by spicer (1907) and others in 
which infected tonsils seem to have aetiological significance by Looper 
(1926) Finnoff (1921-22) Swab (1935) knapp (1935) and Neubauer and 
Radan Hauser (1962) 
4. Endocrine factors have for many years been cited as aetiological agents, 
usually in a vague way, but particularly stress has been placed on such 
factors as menstruation (power 1881) the sexual glands (Hutchionson 
1881, Clegg 1961, Mawas & Hershberg 1953 and others) and 
hyperthyroidism (Arloing and Rainaud 1930; Godde Jolly 1961) There is 
little substantial evidence to prove these. 
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5. Constipation was originally cited as a primary cause by Eales (1880) and 
although others agreed no importance is now attached to the association. 
6. A dietary deficiency of vitamin C has been suggested (Ciotola & Bosoni 
1941, Zwiasses etal 1948) 
7. Parasitic infestation is prevalent in the Indian subcontinent possible 
association of ascaris lumbricoides with eales disease was proposed. The 
authors have done humoral antibody levels against toxocara canis and 
ascaris antigens in 18 serum samples from eales patient and 18 from 
healthy control by Elisa. There was no difference between the level of 
IgM and IgG antibodies to toxocaracanis and ascaris between eales 
patients and controls. 
8. Neurological involvement-various neurological lesions such as multiple 
sclerosis, acute or subacute myelopathy, multifocal white matter 
abnormality, cerebral stroke, intra nuclear ophthalmoplegia, spastic 
paraparesis, chronic progressive non-compressive myelopathy and 
hemiplegia, have been reported in isolated case reports in eales disease. 
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RETINAL VASCULITIS MIMICKING EALES’ DISEASE 
SYSTEMIC OCULAR 
Behcet’s disease Bird shot Retinochoroidpathy 
Leukaemia Coats’ disease 
Lyme borreliosis Pars Planitis 
Multiple sclerosis Viral retinitis 
Sarcoidosis  
Syphilis  
Systemic Lupus erythematosis  
Toxocariasis  
Toxoplasmosis  
Tuberculosis  
Wegner’s granulomatosis  
 
9. Other systemic disease association 
Several systemic infectious disease have been claimed to be associated 
with eales disease. These include focal sepsis hematological disorders 
like acanthocytosis and abnormal red cell morphology. 
Recently Elles and coworkers have reported a case of eales disease 
with evidence of factors V leiden mutation. The authors felt such an 
abnormality could be responsible for thrombosis of retinal vessels and 
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closure of capillary beds in the retinal periphery. Such abnormality could 
also probably be responsible for some cases of eales disease with cerebral 
stroke. In a study in North America vestibuloauditory disturbances have 
been reported in a group of patients with eales disease, however in a case 
control study of eales disease patients in India no vestibuloauditory 
disturbances were found.   
SYSTEMIC DISORDER ASSOCIATED WITH EALES’ DISEASE 
Tuberculosis  Abraham, Ashton, Bonnet, Finoff, Gupta, wagner, Verhoeff & Simpson. 
Hypersensitivity to tuberculoprotein  Elliot, Donders. 
Thromboangitis obliterans Marchesani, Benedict & Wagner, Wagner, Schmid. 
Neurological disease   
 Multiple sclerosis Fielo & Foster, Opala et al 
 Acute or subacute myelopathy Singhal & Dastur 
 Multifocal white matter 
abnormality  Masson et al  
 Cerebral stroke Gardon et al 
Focal sepsis Haematological 
abnormalities Putanna  
 Acanthocytosis  Kahan et al, Rahi et al, Jain et al. 
 Increased plasma viscosity, 
erythrocyte rigidity and 
erythrocyte aggregation 
Bertrams et al 
 Hypereosinonhilia  Bryselhout et al 
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10. Immunology and immunopathology-several investigators have proposed 
immunogenic mechanism in eales disease. Apart from hypersensitivty to 
tuberculoproteins systemic immunological or autolmmune reactions to 
retinal autoantigens have been proposed. Recent studies indicated class I 
and class II HLA association in this disease. Light microscopic and 
immunohistochemical studies of epiretinal membrane and subretinal 
membrane in eales disease have demonstrated lymphocytic infiltration 
predominantly with T cells. This study indicated that a cell mediated 
immune mechanism might be playing a role in the proliferative phase of 
disease with membrane formation on the surface of the retina. 
 
IMMUNOLOGICAL STUDIES IN EALES’S DISEASE 
IMMUNOGLOBULIN LEVELS 
a. Normal immunoglobulin level 
Muthukaruppan et al, 
Koliopoulos et al 
b. Leukaemia  Johnson et al 
Normal T Lymphocyte subsets, antibody response 
to BCG and retinal S-antigen 
Muthukaruppan et al 
Increased level of circulating immune complexes Andrews et al 
Normal level of class I Histocompatibility antigen 
(HLA) 
Bertrams et al 
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11. Recently saxena and co-workers studied lymphocyte proliferative 
response against retinal s-antigen. Its uveito pathogenic peptides, yeast 
histone H3 peptide and uveito pathogenic fragments of inter 
photoreceptor retinoid binding protein (IRBP). Six out of 24 eales disease 
patients showed significant proliferative response against retinal s-
antigen, its uvietogenic fragments and IRBP. None of the controls 
showed any response to retinal antigen or IRBP. 
However such, cellular immune response to retinal antigen and their 
fragments have been seen in patients having Behcets disease. Bird-short 
retino choroidopathy, parsplanitis, ocular sarcoid, sympathetic 
ophthalmia and vogt-koyanagi-Harada disease. This was probably non-
specific and occurred due to breakdown of blood retinal barrier thereby 
exposing the immune system to these retinal auto antigen.  
 
PATHOLOGY 
 
 Despite the heterogeneous etiology of eales disease. It has a common 
pathogenic mechanism. In this mechanism the essential factors is a chronic and 
incomplete vascular occlusion with resultant tissue hypoxia. This is thought to 
stimulate the irregular enlargement of existing capillaries, development of 
capillary aneurysm and retinal neovascularisation. 
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 Donders has shown that the predominant features of eales disease is 
patchy, perivascular or intramural infiltration of lymphocytes or a granulation 
tissue. Occasionally with but usually without giant cells. Vasculitis usually 
starts in the retinal periphery and extends posteriorly. The eales lesion passes 
through inflammatory, obliterative and proliferative phases. The obliterative 
phases is not due to a single process. But is the result of endothelial proliferation 
thrombosis and / or terminal fibrous occlusion. The later process produces the 
sheathing of the involved segment of veins seen ophthalmo scopically.  
 
The proliferative phase is the response of the uninvolved segment of the 
neighbouring vessel. The changes include dilatation, tortuosity, micro aneurysm 
and / or new vessel formation. 
 
 Microscopic study of vitreous aspirate in eales vitreous 
hemorrhage, showed organized vitreous hemorrhage with an evidence of 
membrane formation and peri vascular round cells. The later finding suggest, 
chronic inflammatory process around the vessel wall.  
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CLINICAL FEATURES  
 
 Eales disease with a characteristic clinical picture, flourescein angio 
graphic finding and natural course is considered a specific disease entity. 
Patients are often asymptomatic in the initial stages of retinal perivasculitis 
some patients may develop symptoms such as floaters, blurring of vision, or 
even gross diminution of vision due to massive vitreous haemorrhage. In a 
series of eales disease cases 75% patients were found to have black spots or 
floaters and 60% suffered pain free dimness of vision. 
 
 Vision in these patients can be normal to hand movements or light 
perception only. Bilaterality is quite common (50-90% of the patients) 
 
 Clinical manifestations of this disease is due to three basic pathological 
changes.  
1. Inflammation (Peripheral retinal perivasculitis) 
2. Ischemic changes (Peripheral retinal capillary non-perfusion 
3. Neovascularisation which often leads to vitreous haemorrhage.  
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Anterior uveitis is uncommon is eales disease. However in the severe 
active periphlebitis stage spillover anterior uveitis may occur. Such anterior 
uveitis is always non-granulomatous. The presence of granulomatous anterior 
uveitis should lead one to suspect existence of sarcoid uveites which mimics 
eales disease. Hypopyon is not seen in eales disease and may indicate behcet’s 
disease.  
 
INFLAMMATION 
 It is a common manifestation of eales disease. Signs and symptoms of 
eales disease occur at varying times in the course of the disease but are less 
common in the late stages.  
 Vascular sheathing in found in upto 80% of patients with involvement 
ranging from thin white line limiting the blood column on both sides to heavy 
exudative sheathing. The thin white line tend to be continuous and the heavy 
exudative sheathing is usually segmental. 
 Areas of vascular sheathing frequently leak dye on flourescein 
anglography. However the sheathing does not always correspond to the staining. 
Additionally the intensity of dye leakage seen with flourescein anglography is 
not always proportional to the activity of the inflammatory process. Superficial 
flame shaped haemorrhages are often located in the area of sheathed vessels.  
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 Patients frequently have cells and debris in vitreous. Macular edema also 
occurs in the eye with sheathing and is more common when epi-retinal 
membrane are present.  
 
NON-PERFUSION 
 
 All patients with eales disease have varying degree of peripheal retinal 
perfusion. The non-perfusion is essentially confluent, with temporal quadrant 
most commonly affected. Intra retinal haemorrhages often first appear in the 
affected area followed by vascular tortuosity with frequent collateral formation 
around occluded vessels. Fine solid white lines representing the remains of 
obliterated large vessels are commonly seen in the area of non-perfusion. The 
fine lines retain the configuration of the normal retinal vasculature. 
 
 The junction between the antero-peripheral non-perfusion and the 
posterior perfused retina is usually sharply demarcated. Elliot and spitnaz have 
carefully documented the vascular abnormalities at the junction between 
perfused and non-perfused area. These include microanerysm, arterio-venous 
shunt, venous beading and occasionally hard exuate and cotton wool spots.  
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 Despite extensive peripheral non-perfusion the macula is usually spared, 
preserving central vision. However in some patients the non-perfusion extends 
to the macula. 
 
 Patient with eales disease can also develop branch vein occlusion. The 
branch vein occlusion is either solitary or multiple. One can distinguish BRVO 
in eales from primary BRVO as the latter remains confined to the affected 
where eales disease usually shows some patches of active or healed 
perivasculitis or alteration in other quadrants.  
 
NEO-VASCULARISATION  
 
 It is observed in 80% of patients with eales disease. New vessele can be 
from either on the disc (NVD) or else where (NVE) within the retina. NVE is 
usually located at the junction between the perfused an non-persued area of 
retina. These patients can develop rubeosis iridis. Haemorrhage from the neo-
vascularisation is common and is one of the major cause of visual loss. Retinal 
neo-vascularisation is frequently associated with a prominent fibrous 
component. They may have extensive retinal and vitreal proliferation of 
relatively avascular interlocking strands and sheets of fibrous scar tissue. These 
eyes have associated antero-posterior vitreo-retinal traction and are at a risk of 
developing retinal detachment. 
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 Ophthalmoscopic findings in eales disease often vary and depend on the 
stage of the disease. Arterioles are some times affected along with veins.  
 
 Active retinal perivasculitis was seen in only 5% of cases. Healed 
perivasculitis was often seen as the sheathing of the veins. Other vascular 
changes include sclerosed cord of venules, irregularity of vein caliber, 
pigmentation along venules, kinky venules, abnormal vascular anastomosis and 
veins pulled into the vitreous cavity. Active or healed choroiditis was not seen 
in eales disease. It present it should have led us to suspect the presence of 
simulating disease such as sarcoidosis, tuberculosis orsyphils. However a few 
small chorioretinal atrophic patches close to the retinal vessels were seen. 
Central retinal periphlebitis is markedly uncommon compared to peripheral 
retinal periphlebitis. Such central involvement is often limited to one or more 
venous trunks. It was classified as central eales, a variant of classical eales 
disease.  
 
 Macular changes were relatively uncommon. The most common macular 
change seen was macular edema. Other changes included exudates in the 
macula and epimacular membrane. Rarely was subhyaloid haemorrhage. 
Macular hole and submacular fibrosis observed. Peripheral retinal 
neovascularisation of the retina was quite frequently seen in eales disease and 
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was reported in 36-81% of cases. Optic disc neovascularisation was 
significantly uncommon observed in 9% of cases in one series.  
 Dense vitritis is uncommon in eales disease, however mild overlying 
vitreous haze can be seen in the area of active retinal vaculitis. Recurrent 
vitreous haemorrhage is often the hallmark of this disease the cause of vitreous 
haemorrhage is such eyes is often bleeding from retinal or disc 
neovascularisation, but it can also occur due to rupture of capillaries or large 
venules during the active inflammatory stage. In such case, following resolution 
of vitreous haemorrhage no neovascularisation is detectable clinically or by 
flourescein anglography. 
 
 Surface neovascularisation or neovascular vitreous fronds were seen in 
50% of eyes. In the patients who underwent vitreous surgery tractional and 
rhegmatogenous retinal detachment were observed in combined traction – 
rhegmatogenous retinal detachment a break was observed at the base of vascular 
proliferation. 
 
FUNDUS FLUORESCEIN ANGIOGRAPHY (FFA)      
 Though FFA is not routinely needed to distinguish all cases of eales 
disease, FFA is beneficial in the ischaemic stage to delineate area of capillary 
nonperfusion retinal and/or optic disk neovasculariation and questionable 
macular edema.  
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 In case of active retinal vasculitis, staining of the veins can be seen in the 
early venous phase with extravasation of the dye in the late phase. This is highly 
characteristic of active local inflammation in the retinal vessels. Adjacent retina 
can also show increased permeability and diffuse leakage. In the healed stage of 
vasculitis only the staining of the vessel wall occurs without only leak in the late 
venous phase. Venous obstruction and venous stasis can well be visualized by 
FFA, which will show complete nonperfusion (BRVO) or relative dilatation and 
tortuosity of veins distal to the stasis. Areas of capillary closure, engorged and 
tortuous capillaries and veno-venous shunts can also be seen in the ischaemic 
stage of the disease. 
 
 The extent and location of neo-vascularisation can be precisely delineated 
by fundes flourescein angiogram. Neovascularsation, if present can be quite 
characteristic with sea fan appearance with intense hyperflourescense in the 
early arterio-venous phase of the fundus flourescein anglogram. Such 
neovascularisation usually leak in the late venous phase. Neovascuslarsation 
when located in the far periphery can be missed on routine FFA. FFA often 
helps to delineate the location and extent of retinal ischemia and can be of 
guidance while performing laser photocoagulation. It also helps to evaluate the 
adequacy of photocoagulation and the need for additional laser 
photocoagulation, when FFA is repeated on a follow up visit.  
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 FFA is used to identify subtle changes in the macula for example macular 
edema, epimacular membrane and so forth.  
 
ULTRA SONOGRAPHY 
 
 Ultra sonography is needed to rule out any associated retinal detachment, 
either tractional, rhegmatogenous or combined, in an eye with opaque media. 
Early vitreous surgery is indicated if such association is demonstrated. 
Ultrasonography usually reveals echoes of variable density depending on the 
compaction of vitreous haemorrhage. Both incomplete and complete posterior 
vitreous detachment with or without tractional retinal detachment can be seen. 
Membrane in the vitreous cavity vitreous schisis and fibrovascular proliferation 
may be demonstrated.  
 
BIOCHEMICAL STUDIES  
 
 Several biochemical studies have been done on the serum and vitreous 
samples of patients with eales disease. Pratap etal have found raised alpha  
globulins and decreased albumin levels in the serum samples of patients with 
eales disease.  
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BIOCHEMICAL ABNORMALITIES IN EALES’ DISEASE 
Rise in alpha-globulins & 
reduced albumin level 
Pratab et al 
Abnormal protein band of pI 
5.9 and molecular weight of 
23KD 
Rengarajan et al 
Raised Serum alpha-1 acid 
glycoprotein level 
Sen et al 
 
 Oxidative stress has been implicated in the pathogenesis of various 
diseases. In uveitis the damage inflicted on the ocular tissues due to reactive 
oxygen species has been reported by Rao etal. Armstrong etal have 
demonstrated elevated lipid peroxides in retinal neovascularisation incase of 
diabetic retinopathy where there was no inflammation. They have proposed a 
mechanism whereby the lipid peroxides induced the syntheses of cytokines and 
growth factors in the retina during neovascularisation. From the above 
observation it was predicted that in eales disease with inflammation and 
neovascularisation, free radicals and lipid peroxide products might accumulate 
due to oxidant insult over powering anti oxidant defense.  
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Accumulation of thiobarbituric acid reacting substance (TBARS) was an 
index of the production of excessive oxidant. Where as a deficiency of vitamin c 
and E was an indication of the weekened anti oxidant defense. VIT E deficiency 
could cause deficiency of VIT A needed for retinal physiology. The estimation 
of TBARS and vitamin C, E and A in erythrocytes of eales disease patients 
revealed decreased level of anti oxidants. 
 
 Sulochana and coworkers have identified purified and characterized an 88 
KDa protein from the serum and vitreous of eales disease patients the partial N 
terminal sequence (28amino Acids) revealed this protein to be unique. This 
protein is a glycoprotein and exhibits anti TBARS activity in vitro.  
 
Polyclonal antibody has been produced against this purified protein and 
using this antibody it has been demonstrated that the 88KDA protein variously 
present in the vitreous and serum of eales disease patients was immunologically 
identical. 
  
Since patients have profound oxidative stress characterized by decreased 
antioxident vitamin E and C and increased accumulation of lipid peroxides 
supplementation of antioxidants might be beneficial. 
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DIFFERENTIAL DIAGNOSIS  
 Differential diagnosis of eales disease depends on the stage of 
presentation of disease.  
Clinical presentation can be  
1. Peripheral retinal perivasculitis in one or both eyes. 
2. Neovascular proliferation of retina or optic disc with peripheral retinal 
perivasculitis in the same or other eye. 
3. Vitreous haemorrhage with peripheral retinal pervasculitis in the same or 
the other eye.   
In the last two situations in young healthy adults in the Indian 
subcontinent a strong clinical suspicion of  eales disease in quite justified. The 
diagnosis of eales disease in active perivasculitis stage can sometimes be 
challenging.  A set of laboratory test in retinal vasculitis in the absence of 
medical history suggestive of underlying systemic disease has been found to be 
non-contributory. Sarcoidosis can often mimic eales disease in the active 
inflammatory stage.  
Parsplantis patients can have retinal periphlebitis close to parsplana 
exudate, however retinal haemorrhages, vascular alteration and retinal 
neovascularsiation are absent in pars planitis.  
FFA is an important ancillary test in eales disease and is required in the 
ischemia or proliferative stage of eales disease. 
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 Retinal vasculitis with features suggestive of ischemia has been noted to 
have a high incidence of development of systemic disease. 
 
NATURAL COURSE 
 
 The natural course is quite variable with temporary or even permanent 
remission in some cases and relentless progression to total blindness. Retinal 
ischaemia stimulate neovascular growth from the surrounding normal 
vasculature the common site is just proximal to the site of obstruction. The 
retinal and disc new vessels are the most important cause of repeated vitreous 
hemorrhage. The regressed new vessels get replaced by glial tissue. The glial 
tissue on contraction causes several retinal complication. The macula may get 
distorted or detached the regressing new vessel often get pulled into the vitreous 
usually a tear develops at the point were the venule draining the neo vascular 
lesion joins the retina. This leads to rhegmatogenous retinal detachment.  
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DAS AND NAMPERUMALSAMY GRADING OF EALES 
RETINOPATHY 
GRADING OF EALES RETINOPATHY 
Grades 
Description of 
Lesion  
I Mild II Moderate III Advanced 
IV  
Very 
Advanced 
Angiopathy Venous 
changes 
(Tortuousity, 
Periphlebitis) 
< 1/12 < 2/12 < 3/12 < 3/12 
Microaneurysms 
Retinal Heme 
< 1/12 < 2/12 < 3/12 < 3/12 
Proliferative 
Retinopathy 
    
New Vessels  - < 1/12 < 2/12 < 2/12 
Fibrous tissue 
proliferation 
< 1/12 < 2/12 < 3/12 < 3/12 
Vitreous 
hemorrhage  
< 2/12 
obscured 
< 4/12 
obscured 
< 8/12  
obscured 
< 8/12  
obscured 
1/12 = 30o of an arc 
 
          This classification was useful in assessing and monitoring the effect of 
treatment in eales disease.   
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MANAGEMENT OF EALES DISEASE  
 
Management of eales disease depends on the stage of the disease. It 
includes non-treatment with periodic evaluation in the regressed stage of 
periphlebitis or fresh vitreous haemorrhage. Treatment with oral or periocualr 
steroid in the active perivasculitis stage and laser photocoagulation in case of 
neovascularisation of retina or optic disc, or gross capillary non perfusion 
vitreous surgery is indicated in non-resolving vitreous haemorrahage (more than 
3 months) any associated retinal detachment will however warrant early vitreo 
retinal surgery. 
The role of anti coagulant hyperbaric oxygen and anti-tubercular therapy 
remains contro versial.      
 
Management Options Include:  
a. Observation 
b. Medical  
c. Photocoagulation 
d. Vitreoretinal surgery  
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A. OBSERVATION :  
Patients with inactive retinal vaculitis can be observed periodically at 6 
month to 1-year interval. Patient with fresh vitreous hemorrhage also are asked 
for observation at intervals of 4-6 weeks if under lying retina is found to be 
attached by IDO or by ultra sound such vitreous hemorrhage often clears by 6-8 
weeks. 
 
B. MEDICAL THERAPY :  
Corticosteroid remain the main stay of therapy in the active perivaculitis 
stage of eales disease. The efficiency of corticosteroids has been proven in 
idiopathic retinal perivasculitis. Dosage must be tailored for each patient on the 
basic of severity of inflammation. 
In the majority of cases oral prednisolane 1mg/kg of body weight is 
needed this is tapered to 10 mg per week over 6-8 weeks. Some patients may 
require a maintenance dose of oral prednisolone 15-20 mg/day for 1-2 months. 
In case of associated macular edema one may add periocular depot steroid 
injection. 
Efficiency of systemic or periocular corticosteriod in the inflammatory 
stage of eales disease was studied in a nonrandomized clinical trial where 
systemic steroid and post subtenon injection of steroid were found beneficial if 
there was involvement of three quadrants with CME 
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Systemic corticosteroids alone were helpful when there was two-quadrant 
involvement. In the case of 1 quadrant involvement periocular corticosteriods 
were administered. The natural course of eales disease remained unaltered 
inspite of steroid therapy. There was no difference in response to treatment in 
mantoux – positive and mantoux – negative groups of patients.  
 
As many investigators believe that hypersensitivity to tuberculoproteins 
play a role in the etiology of eales disease, anti-tubercular treatment has been 
given in eales disease empirically. 
 
In patients with a positive mantoux test and active perivasculitis some 
investigators have recommended treatment with a combination of oral 
corticosteriods and anti tubercular therapy. 
 
The role of ATT drugs in the treatment of their disease remains 
controversial. The disease having a variable course and known to be self-
limiting. 
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C.PHOTOCOAGULATION:  
Photocoagulation is the mainstay of therapy in the proliferative stage of 
eales disease. In case of gross capillary non-perfusion photocoagulation is 
suggested. 
 
 Historically meyer schweckerath first used xenon arc photocoagulation 
for eales disease. Subsequently others have reported the efficiency of 
photocoagulation in the proliferative stage of eales disease. Combined xenon arc 
photocoagulation in the paracentral zone and anterior retinal cryopexy in the 
periphery have been used successfully. Currently laser photocoagulation is 
mostly used due to the obvious advantage of reaching the retinal periphery 
where retinal ischemia and neovascularisation are mostly observed. Although 
argon green laser is most commonly used, in case of significant cataract or mild 
vitreous haemorrhage red krypton laser can be effectively used. Such a laser can 
now be delivered through a slit-lamp delivery system or an indirect 
ophthalmoscope.  
Following vitrectomy an endolaser probe or indirect ophthalmoscope 
laser can be used for laser delivery on the operating table. The aim of 
photocoagulation in eales disease to regulate the circulation by diverting blood 
from hypoxic areas to healthy retina thereby decreasing the formation of 
vasoproliferative factors to obliterate surface neo-vascularisation and close 
leaking intraretinal microvascular abnormalities. 
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 In patients with retinal neovascularisation direct treatment with 
moderately strong overlapping burns is suggested. In case of elevated 
neovascularisation photocoagulation of the feeder vessel beneath the frond is 
done. Aneurysm and arteriovenous shunt vessels are also treated in a similar 
way. 
 For gross capillary non-perfusion sectoral scatter photocoagulation is 
suggested. Panretinal photocoagulation is necessary when there is optic dice 
neovascularisation. There could be minor complications associated with laser 
photocoagulation. Retinal haemorrhages are possible in a few cases but major 
bleeding is uncommon with proper selection of the intensity and other 
parameters of photocoagulation. Occasionally following photocoagulation 
retinal gliosis laid down by regressing new vessel undergone further contraction 
and causes a variety of retinal complication such as macular distortion due to 
epiretinal membrane formation and retinal tear resulting in retinal detachment. 
 Laser photocoagulation is not advised in active inflammatory stage as 
there is chance of worsening of neovascularisation due to several angiogenic 
factors liberated. Once the inflammation is subsided with the anti inflammatory 
medications such as corticosteroids, laser photocoagulation can be done. 
D. VITREORETINAL SURGERY  
 Vitrectomy alone or combined with other vitreoretinal surgical 
procedures is often required in eales disease, vitrectomy is often not needed in 
the first episode of vitreous haemorrhage such patients should be advised to 
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keep their head elevated while sleeping. This permits the haemorrhage to settle 
down. 
 The vitreous haemorrhage usually clears between 6 and 8 weeks. 
Ultrasonography should always be performed to exclude the presence of 
associated retinal detachment. Cases of non-resolving vitreous haemorrahage 
with obscurration of central vision of 3 months duration may be subjected to 
vitrectomy. Vitrectomy done between 3 to 6 months has better visual outcome 
than done after 6 months. In the presence of tractional retinal detachment 
extensive vitreous membrance or epimacular membrane early vitrectomy can be 
considered. If preoperative ultrasonography reveals a complete posterior 
vitreous detachment vitreous surgery can be easy and less complicated. 
The aim of vitreous surgery is to clear the vitreous opacities and also to 
evaluate the fundus for any retinal neovascularisation. Along with vitrectomy 
laser photocoagulation can be performed by endophotocoagulation or indirect 
laser delivery system. A standard three-port pars plana vitrectomy is the method 
of choice. Excision of the posterior hyaloid face and clearing of sub hyaloid 
blood are needed. Epimacular membranes can be peeled following vitrectomy. 
Visual results following vitrectomy in eales disease were generally good. Visual 
improvement was seen in 77-88.6% patients following vitrectomy in eales 
disease. Intraoperative complications following vitreous surgery included 
recurrence of vitreous hemorrhage, cataract, rubeosis iridis and neo vascular 
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glaucoma. Patients with fewer episodes of vitreous haemorrahage and 
preoperative laser photocoagulation had better visual prognosis.  
E. ANTERIOR RETINAL CRYOABLATION 
 Anteriors retinal cryoablation has been successfully tried in eyes with 
vitreous haemorrhage caused by PDR while primary ARC is considered in small 
undilating pupil, hazy ocular media due to cataract, after cataract or residual 
vitreous Hemorrhage in eales disease.  It is usually reserved on an adjunct to 
photocoagulation in eales disease. 
RECENT ADVANCES 
 
VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS  
Scatter photocoagulation can cause regression of retinal neo-
vascularisation and reduce the risk of   severe vision loss. However this 
anatomically destructive treatment may be associated with side effects during 
such treatment.   Because VEGF has been showed to play a role in retinal neo-
vascularisation anti VEGF treatment have been hypothesized, as an alternative 
adjunctive treatment for retinal neo vascularisation. Evaluation of anti VEGF 
drugs for diabetic retinopathy have concentrated upon their role in the 
management of diabetic macular edema.          
   VEGF inhibitors Lucentis (ranibizumab) in macular edema due to eales 
disease  are under clinical trial.  
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SECTION - II 
A CLINICAL STUDY ON EALES DISEASE 
 
AIM OF THE STUDY  
1. To determine various epidemiological factors   
2. An attempt to find out the aetiology. 
3. To describe the commonest presentation. 
4. To look out for systemic involvement and association with tuberculosis. 
5. To assess the effectiveness of various treatment modalities. 
6. To assess the visual prognosis.   
 
MATERIALS AND METHODS  
72 cases of eales disease patients who attended the retina clinic of 
Regional Institute of Ophthalmology and Government Ophthalmic Hospital, 
Egmore, Madras - 600 008 between January 2005 to September 2006 were 
taken up for study. 
 
CRITERIA FOR INCLUSION    
 All cases diagnosed as eales disease were taken up for study. Cases were 
diagnosed as eales on the basis of inflammation, not confined to 1 quadrant, 
neovascularisation with vitreous hemorrhage, when other causes of vitreous 
hemorrhage was rules out.  
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 A standard proforma was used to collect and document all the details 
regarding the cases included in the study. 
 After collecting detailed information regarding history and complaints a 
thourough examination of the anterior segment was done with a slit lamp. 
Retinoscopy was done for all cases with a clear media to assess the refractive 
status. For the examination of the posterior segment all the cases were subjected 
to direct ophthalmoscopy indirect ophthalmoscopy and three-mirror 
examination. 
 Visual acuity and intra ocular pressure were recorded in both eyes of all 
cases.  
 Fundus flourescein angiogrpahy was done for all cases that had atleast 
one eye with a clear media. 5ml of 10% flourescein was used for all cases.  
 
All the cases were subjected to the following laboratory investigations: 
1. Haemogram - Hb% total WBC count, differential count,  erythrocyte 
sedimentation rate.  
2. Peripheral smear.  
3. BP 
4. Chest X-ray 
5. Serum Cholesterol  
6. Urine albumin / sugar. 
7. Mantoux. 
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8. C reactive protein. 
9. Blood VDRL 
10. Blood Sugar 
11. Bleeding time / clotting time 
12. Elisa for HIV 
All the cases were referred to the following departments attached to the 
Madras Medical College on need when there was evidence of involvement.  
1. Chest Clinic 
2. Dental Clinic  
3. Rheumatology Clinic  
4. Dermatology Clinic 
5. ENT Clinic 
6. Neurology Clinic 
Based on the clinical features and the results of various investigations 
diagnosis was made and a standard treatment protocol was followed.  
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ANALYSIS AND DISCUSSION 
AGE INCIDENCE 
 
 AGE GROUP NO.OF PATIENTS 
19-29 56 
30-33 9 
34-40 7 
 
Among the 72 cases 56 cases were in the 19 - 29 years age group (77.8 %). The 
earliest age at which the disease has been seen was 19 years.  
[Eales has reported the age of incidence between 19 - 21 years.]  
[Elliot in 1954 reported the average age of incidence as 26.9 years.] 
 
SEX INCIDENCE  
 All the cases diagnosed as eales were male patients. Eales was not 
diagnosed in females.  
[Murphy and collegues in their study of 55 patients in USA found that 
men and women were equally affected]. 
Other studies show 90% of male preponderance. 
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OCCUPATION & SOCIO ECONOMIC STATUS 
 Of 72 patients 36 patients were manual labours, 17 patients were drivers, 
7 patients were painters, 9 patients were carpenters and 3 patients job less.  All 
the patients belonged to poor socio economic status.  
OCCUPATIONS NO OF PATIENTS 
Manual Labours 36 
Drivers 17 
Painters 7 
Carpenters 9 
Job less 3 
 
Commonest affectation seen among manual labours.   
PERSONAL HABITS 
PERSONAL HABITS NO. OF PATIENTS 
Smokers 54 
Non-Smokers 18 
 
75% of the patients were found to be smokers. The smokers are advised to stop 
smoking as it is not known whether it has any relevance with the aetiology. 
[Improvement of general health with change of habits, diet, physical and 
mental rest. (Schiff - Werthimes 1951, Choyce & Cross 1953].
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LATERALITY  
 Of the 72 cases 44 cases were unilateral and 28 cases were bilateral. Of 
the 44 unilateral cases, 41 cases presented with vitreous hemorrhage and 3 
patients presented with neovascularisation in the periphery.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
   
Most of the cases presented unilaterally in our study.  
[Bilaterality is the rule and is found in over 90% of cases if they are observed 
for a period such as 5 years - Duke elder.] 
TOTAL CASES - 72 
UNILATERAL - 44 BILATERAL - 28 
Vitreous Hemorrhage - 41 Neovascularisation - 3
Tractional Bands - 9 
Vitreous Hemorrhage - 4 
Healed Perivasculitis - 3 
Tractional RD - 4 
Neovascular Glaucoma one eye 
Tractional Band other eye - 1 
Neovascularisation  one eye vitreous 
Hemorrhage other eye - 6 
Active Perivasculitis one eye vitreous 
hemorrhage other eye - 1 
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MODE OF PRESENTATION AND REFRACTIVE STATUS 
 
ONSET OF 
SYMPTOMS 
NO. OF 
PATIENTS PERCENTAGE
REFRACTIVE 
STATUS 
NO. OF 
PATIENTS
Acute 45 62.5% Emmetropes 32 
Insidious 27 37.5% Hypermetropes 23 
   Myopes 9 
 
• 62.5% of patients presented with acute onset of symptoms.  
• 37.5% of the patients presented with insidious onset.  
• Of the 72 patients, 32 were emmetrope, 23 hypermetrope , 9 myopes.   
• Refraction was not possible in 8 patients.  
• The incidence of eales seems to be less among myopes.  
• All the myopes were less then - 2D 
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INVESTIGATIONS 
 
INVESTIGATION POSITIVE NEGATIVE 
Mantoux test  9 63 
ESR 12 60 
C-reactive protein - 72 
Peripheral smear - 72 
HIV Status  - 72 
 
• Of the 72 cases, 12.5% of the patients were mantoux positive.  
• 87.5% of the patients were negative.  
• [Elliot (1954) found that tuberculin skin test positive in all his 52 cases 
except one and Donder found 7 negative test in 100 cases.]  
• ESR was raised in 16.6% of patients.  
• C-reactive protein was negative in all patients.  
• Peripheral smear examination was proved to be within normal limits in 
all patients.  
• All patients were HIV negative.  
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SYSTEMIC ILLNESS & FOCAL SEPSIS  
 
Of the 72 patients no associated systemic diseases were detected in any 
patients. Among all cases 4 patients had dental sepsis. 
[Spicer 1907 showed that some of his cases of eales disease had dental 
sepsis. Loope 1920, Fillnoff 1921-22, Neubaur & Roden Bausses 1962 showed 
that some of them had ENT sepsis.] 
 
TUBERCULOSIS  
 
 Of the 72 patients only one patient was on ATT for tuberculoma left 
parietal lobe. 3 patients were old cases of Pulmonary Tuberculosis treated with 
no evidence of active tuberculosis. None other patients had any evidence of 
tuberculosis. 
 
 All patients were investigated for active pulmonary and extra pulmonary 
tuberculosis. X-ray did not show any evidence of pulmonary tuberculosis in all 
72 cases. 
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POSTERIOR SEGMENT MANIFESTATION 
 
POSTERIOR SEGMENT 
MANIFESTATION 
UNILATERAL BILATERAL 
NO. OF 
PATIENTS
Perivasculitis - 4 4 
Neovascularisation 3 6 9 
Vitreous hemorrhage 41 4 45 
Tractional band - 9 9 
Tractional retinal 
detachment 
- 4 4 
Neo vascular glaucoma  1 - 1 
 
 3 patients presented with healed perivasuclitis, 1 patient had active         
perivasculitis in one eye and vitreous hemorrhage in other eye.   
3 patients had unilateral presentation of neovascularisation, 6 cases had 
neovascularisation in one eye with vitreous hemorrhage in other eye.  
All cases underwent scatter argon green laser photocoagulation.     
Of the 72 cases of eales 45 cases presented with vitreous hemorrhage. Of 
the 45 cases, 41 cases had unilateral and only 4 cases had bilateral vitreous 
hemorrhage. Of the 41 cases of unilateral vitreous hemorrhage 22 cases in the 
right 19 cases in the left.  
 [Some writers have found left eye was usually affected first - Eales 1880. 
Others the right, Donders 1958 and other have observed no significant 
difference.] 
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  Of the 41 unilateral cases of vitreous hemorrhage 1 patients of 
tuberculoma left parietal lobe on ATT developed RD during observation period.  
On the basis of the hypothesis that tuberculosis is the aetiology of eales 
disease anti-tuberculosis treatment has been the most common specific measure 
recommended so far (Von Hipper 1905, Igrersheimer 1910) 
Some reports have claimed good results and some have shown 
disappointing results (Rudd 1950, Wagner & Zintz 1951, Solarski 1955) 
 Of the 72 cases, 9 cases had bilateral Tractional bands and one patient 
had Tractional band in one eye and Neovascular glaucoma in the other eye.  
 4 cases presented with Tractional Retinal Detachment in both eyes and 
were referred for internal procedure.  
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VISUAL ACUITY 
Visual acuity of 100 eyes of 72 patients. 
Visual Acuity Initial Vision 
After 3 Months 
Improvement Static Detorioration 
6/6 - 6/9 17 - 17 - 
6/12 - 6/36 18 - 18 - 
6/60 - 1/60 16 14 2 - 
CFCF - HM 44 40 3 1 
PL+ 4 - 4 - 
NO PL 1 - 1 - 
 
As shown in the tabular column it has been observed that majority of the 
patients with vitreous hemorrhage recovered well and regained good visual 
acuity.  
For others the visual acuity was relatively stable. There was detorioration 
of vision in one case with development of RD.  
2 cases of unilateral vitreous hemorrhage and 4 cases of bilateral vitreous 
hemorrhage had persistence of vitreous hemorrhage after 12 weeks and were 
taken up for vitrectomy. 5 patients had visual improvement and 1 patients vision 
remained static.  
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Although the visual acuity of patients with eales disease range from 
normal to NO PL most eyes retain good acuity – Murphy RP, Renie Wa Proctor 
Lr et al, Survey of patients with eales disease.   
 
MANAGEMENT  
 41 cases of unilateral vitreous hemorrhages were kept under observation 
after doing B scan to rule out associated retinal detachment. Of the 41 cases, 38 
cases of vitreous hemorrhage resolved within 8-12 weeks duration and 
reasonable visual acuity was regained. FFA was done in all cases after 
hemorrhage was resolved and 28 cases underwent scatter argon green laser 
photocoagulation, one patient of tuberculoma left parietal lobe on ATT develop 
RD during follow up and advised vitrectomy with endo laser and internal 
tamponade. 2 cases had persistence of vitreous hemorrhage after 12 weeks due 
to recurrence and were taken up for vitrectomy and vision remained static.  
Of the 28 bilateral cases, 6 cases of neovascularisation in one eye were 
treated with scatter laser and vitreous hemorrhage in the other eyes were kept 
under observation.  
9 cases of bilateral tractional bands not involving macula were kept under 
observation and initial vision was maintained after 3 months of observation. 
Of the 4 cases of bilateral vitreous hemorrhage one eye with longer 
duration of defective vision was taken up for vitrectomy right eye in 3 patients 
and left eye in 1 patient. The other eyes were kept under observation.  
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3  cases of healed perivasculitis in both eyes were kept under observation. 
And vision remained the same after 3 months.  
4 cases of tractional retinal detachment were advised vitrectomy with 
endo laser and internal tamponade.  
1 case of neovascular glaucoma in one eye with NO PL was treated with 
cyclocryopexy. 
1 case of active perivasculitis in one eye and vitreous hemorrhage in the 
other eye was started on steroids tapered after 3 weeks and kept under 
observation. Vitreous hemorrhage resolved in 10 weeks.  
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SUMMARY 
1) 72 cases of eales disease were studied. 
2) 56 cases (77%) were in the age group of 19-29 years of age. The 
earliest age at which the disease has been seen was 19 years of age. 
3) Sex incidence : All the cases were only males. 
4) Laterality : The disease was unilateral in 61.1% of the cases and 
bilateral in 38.8% of cases at the time of presentation.  
5) 75% of patients had an acute onset of symptoms and 25% of patients 
had an insidious onset. 
6) Defective vision was the commonest presentation. 
a. Of the 72 cases, 32 cases were emmetropes 44.4%  
b. 23 cases were hypermetropes 31.9% 
c. 9 cases were myope 12.5% 
d. Refraction could not be done for patients with bilateral vitreous 
hemorrhage and bilateral tractional retinal detachment.    
7) Of 72 patients mantoux was positive in 9 patients 12.5% 
8) Creactive protein was found to be negative in all patients.  
9) ESR was raised in 12 patients 16.6% 
10) All systemic disease like hypertension, diabetes, haemoglobinopathies 
were ruled out. 
11) No systemic involvement was associated with any patients.  
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12) One patient was a known case of tuberculoma left parietal lobe on 
ATT, developed RD.  
13) 2 patients were old cases of treated pulmonary tuberculosis with no 
active lesion.  
14) 46 (63.8%) of patients presented with vitreous hemorrhage of which 
41 patients had unilateral vitreous hemorrhage, 4 patients had bilateral 
vitreous hemorrhage and 1 patient had vitreous hemorrhage in one eye 
and active perivasculitis in other eye.  
15) 9 patients (12.5%) presented with bilateral Tractional bands in the 
periphery not involving the macula. 
16) 9 patients (12.5%) presented with neovascularisation elsewhere of 
which 3 patients had neovascularisation in one eye and other eye was 
normal. 6 cases had neovascularisation in one eye and vitreous 
hemorrhage in other eye.  
17) 3 cases (4.16%) presented with healed perivasculitis in both eyes with 
sheathing.   
18) 4 cases (5.5%) presented with long standing Tractional retinal 
detachment. 
19) One case (1.38%) presented with neovascular glaucoma in one eye 
and Tractional band not involving macula in other eye. 
20) One case presented with active perivasculitis in one eye and vitreous 
hemorrhage in other eye. 
 50
CONCLUSION 
 Eales disease with its characteristic clinical features and flourescein 
angiographic findings is a specific vitreoretinal disease. From this study, it is 
evident that the most common presentation is vitreous hemorrhage in young 
healthy males. It has been observed that the earlier the patient develop the 
disease, the more common the patient may go in for complications and visual 
prognosis was relatively better in patients who had a later onset of disease. If the 
cases are detected early and treated adequately with laser, based on the FFA as 
the hemorrhage resolves, and early intervention of non-resolving vitreous 
hemorrhage prevents visual deterioration. In this study, there was found to be no 
association with any systemic diseases. Eales disease has been delinked from 
systemic tuberculosis. Even in our study, one in 72 cases had active 
tuberculosis. This has statistically insignificant association. Although its aetio 
pathogenesis remains unclear the management options are quiet clear. Systemic 
steroid has been found to be beneficial in the active perivasculitis stage. 
Photocoagulation is indicated in cases with gross capillary non-perfusion or 
retinal neovascularisation. Early vitrectomy in non-resolving vitreous 
hemorrhage  with or without endolaser depending on the retinal status should be 
the sheet anchor of managing these patients. The use of intravitreal VEGF 
inhibitors in preventing / regressing neo vascular retinal changes in eales disease 
should be studied and if effective will be a boon in treating these cases.  
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